Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Manz

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Swiss Medical Weekly|December 5, 2019
Position statement on the use of biosimilars in inflammatory bowel diseaseEmanuel Burri, Pascal Juillerat, Michel H Maillard, et al.
Digestion|October 12, 2012
Therapy of steroid-resistant inflammatory bowel diseaseMichael Manz, Stephan R Vavricka, Roger Wanner, et al.
Digestion|October 12, 2012
First-line therapies in inflammatory bowel diseaseMarc Girardin, Michael Manz, Christine Manser, et al.
Endoscopy|January 26, 2016
Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopistsStephan R Vavricka, Michael C Sulz, Lukas Degen, et al.
Scientific Reports|August 17, 2017
Deregulation of transcription factors controlling intestinal epithelial cell differentiation; a predisposing factor for reduced enteroendocrine cell number in morbidly obese individualsBettina K Wölnerhanssen, Andrew W Moran, Galina Burdyga, et al.
Inflammatory Bowel Diseases|December 17, 2009
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS surveyAlain M Schoepfer, Stephan R Vavricka, Janek Binek, et al.
Inflammatory Bowel Diseases|June 16, 2011
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II surveyStephan R Vavricka, Alain M Schoepfer, Georg Bansky, et al.
Journal of Gastroenterology|June 10, 2023
Hierarchical contribution of individual lifestyle factors and their interactions on adenomatous and serrated polyp riskJihee Kim, Kirti Nath, Kurt Schmidlin, et al.
Journal of Hepatology|June 8, 2023
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristicsSarp Uzun, Carl P Zinner, Amke C Beenen, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Swiss Medical Weekly|December 5, 2019
Position statement on the use of biosimilars in inflammatory bowel diseaseEmanuel Burri, Pascal Juillerat, Michel H Maillard, et al.
Digestion|October 12, 2012
Therapy of steroid-resistant inflammatory bowel diseaseMichael Manz, Stephan R Vavricka, Roger Wanner, et al.
Digestion|October 12, 2012
First-line therapies in inflammatory bowel diseaseMarc Girardin, Michael Manz, Christine Manser, et al.
Endoscopy|January 26, 2016
Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopistsStephan R Vavricka, Michael C Sulz, Lukas Degen, et al.
Scientific Reports|August 17, 2017
Deregulation of transcription factors controlling intestinal epithelial cell differentiation; a predisposing factor for reduced enteroendocrine cell number in morbidly obese individualsBettina K Wölnerhanssen, Andrew W Moran, Galina Burdyga, et al.
Inflammatory Bowel Diseases|December 17, 2009
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS surveyAlain M Schoepfer, Stephan R Vavricka, Janek Binek, et al.
Inflammatory Bowel Diseases|June 16, 2011
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II surveyStephan R Vavricka, Alain M Schoepfer, Georg Bansky, et al.
Journal of Gastroenterology|June 10, 2023
Hierarchical contribution of individual lifestyle factors and their interactions on adenomatous and serrated polyp riskJihee Kim, Kirti Nath, Kurt Schmidlin, et al.
Journal of Hepatology|June 8, 2023
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristicsSarp Uzun, Carl P Zinner, Amke C Beenen, et al.
Pageof 3